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Introduction {#sec1}
============

The search for an appropriate in vitro model for the testis has been ongoing for nearly a century ([@bib16], [@bib19]). In mice, classical organ culture procedures have been adapted and optimized for testicular tissue, thereby achieving complete spermatogenesis from spermatogonial stem cells (SSCs) to the formation of fertilization-competent sperm ([@bib21]). However, an adequate in vitro model for human spermatogenesis has yet to be developed, despite reports of the differentiation of meiotic and post-meiotic germ cells into fertilization-competent gametes ([@bib6]).

Organoid systems take advantage of the self-organizing capabilities of cells to create diverse multi-cellular tissue surrogates that constitute a powerful novel class of biological models ([@bib26]). Clearly, formation of a functional testicular organoid (TO) from a single-cell suspension would be an extremely valuable testicular model. Such de novo formation of testicular tissue, with seminiferous tubules and an interstitial compartment, has been achieved in vitro starting from isolated murine testicular somatic and germ cells without the support of a scaffold. However, in this system, spermatogenesis was arrested at the meiotic phase ([@bib27]). More promising results have been obtained with artificial 3D scaffolds. For example, cultivation of immature rodent testicular cells in a collagen, agarose, or methylcellulose matrix was successful in generating post-meiotic cells ([@bib14], [@bib24]). However, with these approaches, specific cell orientation (normally provided by the basement membrane) is lacking, which might be responsible for its low efficiency. Notably, in a system consisting of immature rat testicular cells in a 3D agarose matrix, spermatogonia without close contact to Sertoli cells stopped developing ([@bib18]).

This problem might be circumvented by using a scaffold that mimics the testicular architecture. Indeed, it is already common in tissue engineering to use scaffolds composed of biological extracellular matrix (ECM) ([@bib3]). In this context, we previously described the preparation of human decellularized testicular matrix (DTM) and its potential use as a scaffold ([@bib1]).

Accordingly, our present goal was to re-engineer the human testicular microenvironment, including its major cellular and structural components in TOs by adding isolated suspensions of somatic and germ cells to natural testicular scaffolds. In parallel, the self-assembling capability of human testicular cells into TOs was assessed in the absence of scaffold support.

Results {#sec2}
=======

Formation of Scaffold-Based and Scaffold-Free TOs {#sec2.1}
-------------------------------------------------

To generate scaffold-based TOs, testicular cells from adult and pubertal individuals were seeded into the apical compartment of hanging transwell inserts containing 90-μm-thick DTM ([Figure 1](#fig1){ref-type="fig"}A). In a preliminary study, we determined the thickness of DTM that was optimal for cell growth with the tubules still being accessible ([Figure 1](#fig1){ref-type="fig"}B, left panel). Following 24 hr of incubation, the adult or pubertal testicular cells had repopulated the scaffolds by invading the tubular structures and settling down in the interstitial compartment ([Figure 1](#fig1){ref-type="fig"}B, right panel). Moreover, the cells in the scaffold were connected to the surrounding non-inoculated cells. Interestingly, with time, the testis scaffold tended to blend into the newly formed TOs. Under scaffold-free conditions, cells first self-assembled into a multi-layered cell sheet. Generally, regardless of scaffold presence, longer incubation times were associated with contraction and condensation of the TOs, finally resulting in spheroid formation after approximately 3 weeks. These spheroid structures were maintained until the end of the observation period ([Figure 1](#fig1){ref-type="fig"}C).

Spatial-Temporal Behavior of Somatic Testicular Niche Cells in TOs {#sec2.2}
------------------------------------------------------------------

In vivo, cells co-expressing the molecular steroidogenic acute regulatory protein (STAR) and steroidogenic 3β-hydroxysteroid dehydrogenase (3βHSD) markers are Leydig cells located in the interstitium ([Figure S1](#mmc1){ref-type="supplementary-material"}, top-left panel). Patches containing STAR^+^/3βHSD^+^ cells, representing steroidogenic Leydig cells were observed for as long as 1 month in scaffold-based TOs ([Figure 2](#fig2){ref-type="fig"}, top row).

In normal testicular tissue, COL1 is typically present in the interstitium, vascular wall, and tubular wall, the latter also harboring ACTA2^+^ peritubular myoid cells (PTMCs) ([Figure S1](#mmc1){ref-type="supplementary-material"}, middle-left panel). In the nascent TOs, randomly distributed round-shaped ACTA2^+^ cells were attached to the testicular scaffold, which stained positively for COL1. As expected, given that PTMCs are the major producers of ECM in the testis, staining for COL1 was also localized in the cytoplasm of some ACTA2^+^ cells. Remarkably, ACTA^−^ cells were also seen to produce COL1. Later, the testis-specific pattern of COL1 distribution in TOs was replaced by a widespread network of COL1 fibers with interspersed elongated ACTA2^+^ PTMCs ([Figure 2](#fig2){ref-type="fig"}, middle row), a remodeling pattern in line with our observations in stereomicroscopy. Like Leydig cells, some PTMCs in TOs appear to remain active, as indicated by this elongation and expression of ECM. Furthermore, clumps of SOX9^+^ cells expressing the tight-junction protein ZO1 were also present ([Figure 2](#fig2){ref-type="fig"}, bottom row). In normal testis, SOX9^+^ Sertoli cells actively produce ZO1 as an important part of the blood-testis barrier ([Figure S1](#mmc1){ref-type="supplementary-material"}, bottom-left panel). These results have been reproduced in scaffold-based TOs from pubertal cells ([Figure S1](#mmc1){ref-type="supplementary-material"}, middle and right column). Intriguingly, similar staining patterns were also obtained in TOs formed without scaffold support ([Figure 2](#fig2){ref-type="fig"}, right column). Immunostaining for immunoglobulin G (IgG) controls showed no non-specific signals and are depicted in [Figure S1](#mmc1){ref-type="supplementary-material"} (fourth row).

Spatial-Temporal Behavior of Spermatogonia in TOs {#sec2.3}
-------------------------------------------------

Staining for each of the spermatogonial markers UCHL1, UTF1, and FGFR3 was combined with staining for the germ-cell marker DDX4 to allow unambiguous detection of early and late spermatogonia. In situ, these cells reside singly or aligned at the basement membrane of the seminiferous tubules ([Figure S2](#mmc1){ref-type="supplementary-material"}, left column). Numerous UCHL1^+^/DDX4^+^, UTF1^+^/DDX4^+^, and FGFR3^+^/DDX4^+^ cells were present in all types of TO during the 4 weeks of culture. Spermatogonia appeared as single cells and small clusters, but they also formed larger grape-like aggregates in adult TOs ([Figure 3](#fig3){ref-type="fig"}, first to third row), as well as pubertal TOs ([Figure S2](#mmc1){ref-type="supplementary-material"}, middle and right column).

Importantly, mitotically active germ cells were present in scaffold-based and scaffold-free adult TOs at both early and late time points, as revealed by expression of the protein KI67 by DDX4^+^ cells ([Figure 3](#fig3){ref-type="fig"}, fourth row). Comparable results were obtained in pubertal TOs ([Figure S2](#mmc1){ref-type="supplementary-material"}, second and third column). This is a crucial finding, since proliferation is an essential functional characteristic of spermatogonia. Cells staining positive for DDX4, but not for a spermatogonial marker might be other germ-cell types that originated from the pubertal or adult donor tissue. No background staining was observed with normal rabbit or mouse IgG isotypes ([Figure S1](#mmc1){ref-type="supplementary-material"}, fourth row).

Profile of Hormone and Cytokine Secretion {#sec2.4}
-----------------------------------------

The maintenance of steroidogenic Leydig cells and active Sertoli cells in adult TOs was demonstrated by the detection of testosterone (T) and inhibin B (InhB), respectively, throughout the 4 weeks of culture, with comparable levels in scaffold-based and scaffold-free conditions ([Figures 4](#fig4){ref-type="fig"}A and 4B). The level of hormones produced by pubertal TOs had a tendency to increase gradually with time ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Strikingly, stimulation by gonadotrophins exerted no lasting effect on hormone release by Leydig and Sertoli cells in the TOs ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S3](#mmc1){ref-type="supplementary-material"}A).

At 1 and 4 weeks of culture, the levels of 19 and 21 cytokines, respectively, were above threshold in the medium from at least two adult scaffold-based TOs. Scaffold-free TOs produced totals of 18 and 28 cytokines after short- and long-term culture, respectively. The majority of these cytokines were shared with scaffold-based TOs ([Figures 4](#fig4){ref-type="fig"}C and 4D). Short-term cultured scaffold-free TOs produced 14 cytokines at equal levels, while interleukin-6 (IL-6) was produced in lower amounts compared with scaffold-based TOs (p = 0.0004) ([Figure 4](#fig4){ref-type="fig"}C). After long-term culture, scaffold-free TOs produced GROa (p = 0.0349) and IL-6 (p \< 0.0001) at higher levels and 17 other cytokines at similar levels compared with scaffold-based TOs ([Figure 4](#fig4){ref-type="fig"}D). The cytokines restricted to scaffold-free or scaffold-based TOs are presented in [Figures 4](#fig4){ref-type="fig"}C and 4D. In addition, [Figure S3](#mmc1){ref-type="supplementary-material"}B shows the cytokine secretion profiles associated with short- and long-term cultured pubertal TOs. A complete list of the cytokines assayed, including their full names is provided in [Table S2](#mmc1){ref-type="supplementary-material"} and a representative cytokine antibody array is shown in [Figure S3](#mmc1){ref-type="supplementary-material"}C.

Discussion {#sec3}
==========

In this study, natural testis scaffolds fabricated from DTM were re-cellularized with adult and pubertal testicular cells. Despite the fact that cells entered both the tubular and interstitial compartments, the TOs did not display typical testicular cytoarchitecture and the scaffold was remodeled by the testicular cells over time. This latter process might be initiated by breakdown of the scaffold by enzymes produced by the cells, with subsequent production of ECM proteins that re-organize the tissue.

In the light of their nature, PTMCs and Sertoli cells may have contributed directly to the reshaping of the scaffold. We show here that a number of in vivo testicular processes related to ECM (including the blood-testis barrier) remodeling were recapitulated in TOs derived from both young and adult cells ([@bib8], [@bib17], [@bib23]). First, tumor necrosis factor alpha, tissue inhibitor of metalloproteinase 1, IL-6, and monocyte chemotactic protein 1 were produced, as detected by way of membrane antibody arrays. Second, rearrangement of COL1 fibers from a testis-specific pattern to a widespread interconnecting network occurred with time. Third, functionally differentiated PTMCs producing ECM were detected, first as round and later as elongated ACTA2^+^ cells containing COL1 in their cytoplasm and interspersed between the COL1 fibers. Fourth, co-localization of SOX9, a marker of Sertoli cells, and the tight-junction protein ZO1 in certain cells in the TOs indicated production of protein components of the blood-testis barrier by Sertoli cells. Finally, cells other than PTMCs, possibly Sertoli cells (the other main source of testicular ECM), were found to express COL1. In addition, macrophages may have played a central role as well, especially since these cells participate in the degradation of ECM scaffolds ([@bib25]). Macrophages would be expected to be present in TOs formed from suspensions containing testicular cells, given that immune cells reside naturally in the testicular interstitium ([@bib7]). Thus, remodeling of the scaffold might have involved interactions between PTMCs, Sertoli cells, and macrophages. This phenomenon may be relevant to the observation that degradation products of ECM components, so-called cryptic peptides, regulate tissue functions ([@bib3]). Nevertheless, the necessity of the natural testicular scaffold in TO formation is debatable, given that the spatial-temporal behavior and hormone and cytokine secretion profiles of testicular cells in scaffold-free TOs were comparable.

The spheroid shape of both scaffold-based and scaffold-free TOs might be explained by contraction of ACTA2 proteins in PTMCs in response to androgens, as this occurs in vivo ([@bib22]). Importantly, we found indications of Leydig cells effecting steroidogenesis in the TOs. The presence of cells expressing STAR and 3βHSD, which are critically involved in T biosynthesis, and, in particular, the detection of T in the medium suggest Leydig cell functionality throughout the entire culture period. Interestingly, physiological concentrations of gonadotrophins did not stimulate T production, nor did they influence the production of InhB, an indicator of Sertoli cell functionality. A possible explanation for this lack of effect could be that these cells became unresponsive to stimulation due to the age of the adult testicular cells used in this study ([@bib11]). Alternatively, maximal stimulation was induced by gonadotrophin-like factors in the serum supplement used in the culture medium. Indeed, unresponsiveness of testicular cells to gonadotrophins has been reported before when serum was added to the culture medium ([@bib20]), while a gonadotrophin-induced increase in hormone production was detected in serum-free systems ([@bib2]). Moreover, supplementation of the medium for mouse testicular organ culture with serum alone is sufficient to generate sperm, and, in this setup, lipid-rich albumin plays a critical role ([@bib21]). Unfortunately, many other components of this serum replacement remain unknown. The maintenance of Leydig cells with testis-specific activity was further demonstrated by the production of MCSF, a cytokine important for germ-cell renewal ([@bib15]).

Using three different unambiguous combinations of markers, we found that long-term cultures of scaffold-based and scaffold-free TOs contained early and late spermatogonia. Importantly, throughout the culture period, a proportion of the germ cells stained positive for a marker of proliferation, this being a highly important feature of spermatogonia. However, the number of dividing germ cells appeared to decline with time, which, together with the profile of cytokine secretion, indicates that there is still room for improvement. For instance, certain important inducers of germ-cell renewal, e.g., glial cell-line-derived neurotrophic factor, were not detected by the cytokine array after long-term culture, and, therefore, should perhaps be added to the culture medium ([@bib15]).

The maintenance of the major somatic testicular niche cells with testis-specific functionalities as well as proliferating germ cells documented here represents an important stepping stone for future work on generating haploid cells in TOs. An in vitro model that performs key testicular processes would represent a breakthrough with many valuable applications. Such a model could help unravel the mechanisms involved in both spermatogenesis and underlying disorders. The 2D models currently available are limited and the results obtained difficult to extrapolate to a tissue ([@bib5]), while the presently available 3D culture system is suitable only for short-term evaluations ([@bib12], [@bib20]). In the clinic, a system enabling in vitro spermatogenesis is the missing link in male fertility preservation and treatment of non-obstructive azoospermia ([@bib10]). Going further, pluripotent stem cells from men who completely lack germ cells might be combined with TOs to produce artificial gametes more efficiently than what is currently possible ([@bib9]). Finally, the majority of men and women would welcome a male contraceptive to allow their participation in the control of fertility ([@bib13]). In this context, and also in the field of reproductive toxicology, an in vitro system for human spermatogenesis could be used to screen candidate drugs and chemicals ([@bib5]).

Experimental Procedures {#sec4}
=======================

See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Donor Testicular Tissue and Formation of TOs {#sec4.1}
--------------------------------------------

Fragments of DTM were prepared in the manner we described previously ([@bib1]). These fragments were then cryosectioned into 90-μm discs to obtain testicular scaffolds. Primary testicular cells were isolated from human adult or pubertal testicular tissue by way of two-step enzymatic digestion ([@bib24]). Adult tissue (representing complete spermatogenesis) was donated by six patients undergoing bilateral orchiectomy at the Urology Department, Universitair Ziekenhuis (UZ) Brussel (ethics approval no. 2014/243). All experiments were repeated in triplicate using TOs derived from three different patients. Pubertal testicular tissue was obtained from a 15-year-old who was enrolled in the fertility preservation program at UZ Brussel\'s Center for Reproductive Medicine (ethics approval no. 2015/V9). This tissue exhibited active spermatogenesis up to meiosis. Because immature tissue is very scarce, it was employed solely to confirm the results obtained with adult tissue. Scaffold-based and scaffold-free TOs were formed by pipetting a drop of medium containing 10^6^ cells onto the apical side of a transwell insert containing or lacking a scaffold.

Culture medium (10% \[v/v\] CTS KnockOut SR XenoFree Medium, 1× GlutaMAX and 1% \[v/v\] penicillin-streptomycin diluted in KnockOut DMEM; all from Thermo Fisher Scientific) was added to the basolateral compartment of the well with or without (controls) supplementation with human chorionic gonadotrophin (hCG; Pregnyl; Organon) as a luteinizing hormone analog and/or recombinant follicle-stimulating hormone (rFSH; Puregon; Organon), both at physiological concentrations (5 IU/L) ([@bib4]). The cells were cultured for 4 weeks at the gas-liquid interphase at 35°C in a humidified atmosphere containing 5% CO~2~ ([@bib21]), with change of medium every week or when collecting cultured medium for analysis.

Immunofluorescent Staining of Whole Mounts of TOs {#sec4.2}
-------------------------------------------------

To examine the temporal-spatial patterns of the key testicular cell types (Leydig cells, PTMCs, Sertoli cells and spermatogonia \[including SSCs\]) in TOs, these structures were fixed overnight at 4°C in 4% paraformaldehyde and double immunofluorescent staining of whole mounts was performed. Details of the primary antibodies employed and their targets are provided in [Table S1](#mmc1){ref-type="supplementary-material"}.

Profile of Hormone and Cytokine Secretion {#sec4.3}
-----------------------------------------

To examine the endocrine functionality of Leydig and Sertoli cells in these TOs, the release of T and InhB, respectively, in response to full gonadotrophic stimulation (rFSH/hCG), stimulation with hCG (−/hCG) or rFSH (rFSH/−) alone, or no stimulation (−/−) was determined at different time points during long-term culture. Concentrations of T (DRG Diagnostics) and InhB (Beckman Coulter) were assayed by employing commercial ELISAs in accordance with the manufacturer's instructions.

Antibody arrays targeting 80 human cytokines (ab133998; Abcam) were used to quantify factors associated with the formation of TOs and to assess major changes in their secretion during culture. To this end, medium collected after short-term (1 week) and long-term (4 weeks) culture was subjected to the antibody array assay in accordance with the manufacturer\'s instructions.

Statistical Analyses {#sec4.4}
--------------------

Statistical analyses were performed by employing GraphPad Prism 6 or IBM Statistics 20 (IBM Corporation) software. Levels (means ± SDs) of hormones and cytokines were compared by way of two-way ANOVA. These analyses were followed by Bonferroni post hoc tests for correction of multiple comparisons. A p value of \<0.05 was considered to be statistically significant.
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![Formation of Scaffold-Based and Scaffold-Free TOs\
(A) Schematic illustration of the culture system involving inoculation of testicular cells onto a scaffold to prepare scaffold-based (SB) TOs. Testicular cells were cultured in the apical compartment of the insert without scaffold support to form scaffold-free (SF) TOs.\
(B) A testicular scaffold (red) before (left panel) and 24 hr after (right panel) cell seeding. DAPI was used to stain cell nuclei blue. The inserts show higher magnifications of a seminiferous tubule (^∗^) and the interstitial space (\#).\
(C) Morphological transformation of TOs viewed through a stereomicroscope. The dotted lines delineate the re-cellularized testis scaffold. See also [Table S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Characterization of Somatic Testicular Niche Cells in the TOs by Immunofluorescent Staining of Whole Mounts\
Double staining for STAR/3βHSD (top row), ACTA2/COL1 (middle row), and SOX9/ZO1 (bottom row) applied to scaffold-based (left and middle columns) and scaffold-free (right column) adult TOs (n = 3 TOs derived from different donors per staining). Representative photographs of TOs following short-term (left column) and long-term (middle and right columns) culture are shown. Steroidogenic Leydig cells (white arrows) stained positive for both STAR (green) and 3βHSD (purple), PTMCs (white/red arrows) stained for ACTA2 (green), scaffold (^∗^) and COL1-producing cells (red arrows) stained for COL1 (purple), COL1-producing PTMCs (white arrow) stained for both ACTA and COL1, and tight-junction protein-producing Sertoli cells (white arrow) stained for both SOX9 (green) and ZO1 (purple). Cell nuclei were stained blue with DAPI. The inserts depict several z stacks at low magnification merged with maximum intensity projection to give an overview. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Characterization of Spermatogonia in the TOs by Immunofluorescent Staining of Whole Mounts\
Immunostaining for UCHL1/DDX4 (first row), UTF1/DDX4 (second row), FGFR3/DDX4 (third row), and KI67/DDX4 (fourth row) in adult TOs (n = 3 TOs derived from different donors per staining) derived with (left and middle column) and without (right column) scaffold support following 24 hr (left column) and 4 weeks (middle and right column) of culture. Representative images show cells that stained positive for UCHL1, UTF1, or FGFR3 (green), and DDX4 (purple), which are unmistakably spermatogonia (white arrow). Cells positive for DDX4 alone represent a different germ-cell type (red arrow). The DDX4^+^ (purple) cells staining for KI67 (green) are dividing germ cells (white arrow). Cell nuclei are stained blue by DAPI. The inserts depict low-magnification overviews of the TOs generated using maximum intensity projection of z stacks. See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Secretory Profile of Hormones and Cytokines of Testicular Cells in the TOs\
The levels of (A) T and (B) InhB in the medium were measured after 24 and 72 hr, and 1, 2, 3, and 4 weeks of culturing scaffold-based and scaffold-free TOs under different hormonal conditions (−/−; rFSH/−; −/hCG; rFSH/hCG). Cytokine profiles were obtained by incubating array membranes with medium from scaffold-based and scaffold-free TOs after (C) 1 week and (D) 4 weeks of culture. The data are presented as means ± SDs (n = 3 TOs derived from different donors per condition). For an explanation of the protein abbreviations, see [Table S2](#mmc1){ref-type="supplementary-material"}. hCG, human chorionic gonadotrophin; MPD, mean pixel density; rFSH, recombinant follicle-stimulating hormone; SB, scaffold based; SF, scaffold free. See also [Figure S3](#mmc1){ref-type="supplementary-material"} for the hormone and cytokine secretion profiles of pubertal TOs and a representative cytokine antibody array.](gr4){#fig4}
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